Cancer Biopsy Market, By Product, By Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

Cancer biopsy market size was valued at US$ 32,268.12 Million in 2024, expanding at a CAGR of 8.23% from 2025 to 2032.

A cancer biopsy is a medical procedure used to diagnose cancer by removing a small sample of tissue, fluid, or cells from a suspicious area in the body for laboratory examination. This test helps determine the presence, type, and stage of cancer, guiding doctors in creating appropriate treatment plans. Biopsies can be performed using different methods such as needle biopsy, surgical biopsy, or endoscopic biopsy, depending on the location of the abnormality.

Cancer Biopsy Market- Market Dynamics

Increasing prevalence of cancer among people globally to propel market demand

The global cancer biopsy market is driven by the sharp rise in cancer prevalence worldwide. According to the World Health Organization (WHO), nearly 20 million new cancer cases were recorded in 2022, highlighting the urgency for diagnostic solutions. Governments and health agencies are emphasizing early detection, which directly fuels biopsy demand. However, advanced techniques such as liquid biopsy and next-generation sequencing remain costly, restricting access in low- and middle-income countries.

On the opportunity side, liquid biopsy adoption is accelerating: the U.S. Food and Drug Administration (FDA) has already approved more than 40 companion diagnostics for targeted cancer therapies, ensuring wider clinical integration. Additionally, large-scale government initiatives-such as the U.S. Cancer Moonshot program and the European Union's Beating Cancer Plan-are significantly boosting funding for cancer research and innovation. These combined forces create a market landscape where rising incidence and supportive policy outweigh cost challenges, ensuring sustained global growth.

Cancer Biopsy Market- Segmentation Analysis:

The Global Cancer Biopsy Market is segmented on the basis of Product, Type, Application, End User, and Region.

The market is divided into three categories based on Product: services, instruments, and kits & consumables. The services segment is expected to hold the major market share during the forecast period, driven by rising demand for advanced diagnostic testing, pathology services, and increasing adoption of minimally invasive biopsy procedures worldwide.

The market is divided into twelve categories based on Application: breast cancer, cervical cancer, colorectal cancer, prostate cancer, lung cancer, blood cancer, skin cancer, kidney cancer, ovarian cancer, pancreatic cancer, liver cancer, and others. Among these, the breast cancer segment is expected to hold the largest market share during the forecast period, driven by its high prevalence, rising screening programs, and growing adoption of advanced diagnostic techniques

Cancer Biopsy Market- Geographical Insights

North America cancer biopsy market dominated the global market with over 40% share. The region's lead is reinforced by high incidence rates and strong policy frameworks. According to U.S. Cancer Statistics, 279,731 new female breast cancer cases were reported in 2022, and total cancer incidence continues to rise year-on-year.

Medicare coverage for next-generation sequencing and FDA approvals of liquid biopsy tests, such as Guardant360 CDx, further accelerate adoption. In Europe, the EU Beating Cancer Plan aims to ensure 90% of eligible citizens are offered screening by 2025, while NHS England has expanded liquid biopsy pilots to improve early diagnosis. Asia Pacific is the fastest-growing market: India's ICMR projects 1.53 million new cases in 2024, and Japan reported around 1.01 million new cases in 2022, both significantly expanding biopsy demand. Collectively, policy backing, reimbursement clarity, and rising case volumes sustain North America's lead while Europe and Asia Pacific rapidly close the gap.

Cancer Biopsy Market- Competitive Landscape:

Rising demand for early and accurate cancer diagnosis is driving companies to enhance innovation and efficiency in biopsy solutions. Market participants are focusing on developing minimally invasive biopsy techniques, integrating advanced imaging guidance, and improving molecular testing capabilities to increase precision. Strategic collaborations with research institutions and healthcare providers are being pursued to expand clinical applications. In addition, companies are investing in automation, digital pathology, and AI-powered diagnostics to accelerate results, strengthen accuracy, and gain a competitive advantage.

Recent Developments:

In April 2025, Labcorp launched molecular residual disease and liquid biopsy testing, offering advanced genomic insights to support personalized cancer treatment, improve disease monitoring, and aid in early relapse detection for better patient outcomes across diverse cancer types.

In June 2025, M42 announced a strategic collaboration with AstraZeneca and SOPHiA GENETICS to introduce advanced liquid biopsy testing in the UAE, enhancing cancer diagnosis, treatment decisions, and biomarker testing for improved precision oncology outcomes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER BIOPSY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

QIAGEN
ANGLE plc
Illumina, Inc.
BD (Becton, Dickinson and Company)
Hologic, Inc.
Myriad Genetics, Inc.
Biocept, Inc.
Danaher
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
GRAIL, Inc.
Lucence Health Inc.
Guardant Health Inc.
Freenome Holdings, Inc.
Exact Sciences Corporation
Biodesix (Integrated Diagnostics)
Epigenomics AG
Oncimmune
HelioHealth (Laboratory for Advanced Medicine)
Chronix Biomedical, Inc.
Genesystems, Inc. (Genesys Biolabs)
Personal Genome Diagnostics Inc.
Personalis Inc.
Natera, Inc.
Others

GLOBAL CANCER BIOPSY MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Services
Instruments
Kits & Consumables

GLOBAL CANCER BIOPSY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Liquid Biopsies
Core Needle Biopsy (CNB)
Fine Needle Aspiration (FNA)
Tissue Biopsies
Surgical Biopsies
Needle Biopsies
Others

GLOBAL CANCER BIOPSY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Breast Cancer
Cervical Cancer
Colorectal Cancer
Prostate Cancer
Lung Cancer
Blood Cancer
Skin Cancer
Kidney Cancer
Ovarian Cancer
Pancreatic Cancer
Liver Cancer
Others

GLOBAL CANCER BIOPSY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Diagnostic Centers
Cancer Research Centers
Research & Academics

GLOBAL CANCER BIOPSY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV5676

1. Cancer Biopsy Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Cancer Biopsy Market Snippet by Product
- 2.1.2. Cancer Biopsy Market Snippet by Type
- 2.1.3. Cancer Biopsy Market Snippet by Application
- 2.1.4. Cancer Biopsy Market Snippet by End User
- 2.1.5. Cancer Biopsy Market Snippet by Country
- 2.1.6. Cancer Biopsy Market Snippet by Region
2.2. Competitive Insights

3. Cancer Biopsy Key Market Trends

3.1. Cancer Biopsy Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Cancer Biopsy Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Cancer Biopsy Market Opportunities
3.4. Cancer Biopsy Market Future Trends

4. Cancer Biopsy Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Cancer Biopsy Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Cancer Biopsy Market Landscape

6.1. Cancer Biopsy Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Cancer Biopsy Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
- 7.1.2. Services
- 7.1.3. Instruments
- 7.1.4. Kits & Consumables

8. Cancer Biopsy Market - By Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
- 8.1.2. Liquid Biopsies
  - 8.1.2.1. Core Needle Biopsy (CNB)
  - 8.1.2.2. Fine Needle Aspiration (FNA)
- 8.1.3. Tissue Biopsies
  - 8.1.3.1. Surgical Biopsies
  - 8.1.3.2. Needle Biopsies
- 8.1.4. Others

9. Cancer Biopsy Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 9.1.2. Breast Cancer
- 9.1.3. Cervical Cancer
- 9.1.4. Colorectal Cancer
- 9.1.5. Prostate Cancer
- 9.1.6. Lung Cancer
- 9.1.7. Blood Cancer
- 9.1.8. Skin Cancer
- 9.1.9. Kidney Cancer
- 9.1.10. Ovarian Cancer
- 9.1.11. Pancreatic Cancer
- 9.1.12. Liver Cancer
- 9.1.13. Others

10. Cancer Biopsy Market - By End User

10.1. Overview
- 10.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 10.1.2. Hospitals
- 10.1.3. Diagnostic Centers
- 10.1.4. Cancer Research Centers
- 10.1.5. Research & Academics

11. Cancer Biopsy Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Cancer Biopsy Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Cancer Biopsy Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.17.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Cancer Biopsy Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Cancer Biopsy Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Cancer Biopsy Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Cancer Biopsy Industry

12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. QIAGEN
- 12.2.2. ANGLE plc
- 12.2.3. Illumina, Inc.
- 12.2.4. BD (Becton, Dickinson and Company)
- 12.2.5. Hologic, Inc.
- 12.2.6. Myriad Genetics, Inc.
- 12.2.7. Biocept, Inc.
- 12.2.8. Danaher
- 12.2.9. Thermo Fisher Scientific, Inc.
- 12.2.10. F. Hoffmann-La Roche Ltd.
- 12.2.11. GRAIL, Inc.
- 12.2.12. Lucence Health Inc.
- 12.2.13. Guardant Health Inc.
- 12.2.14. Freenome Holdings, Inc.
- 12.2.15. Exact Sciences Corporation
- 12.2.16. Biodesix (Integrated Diagnostics)
- 12.2.17. Epigenomics AG
- 12.2.18. Oncimmune
- 12.2.19. HelioHealth (Laboratory for Advanced Medicine)
- 12.2.20. Chronix Biomedical, Inc.
- 12.2.21. Genesystems, Inc. (Genesys Biolabs)
- 12.2.22. Personal Genome Diagnostics Inc.
- 12.2.23. Personalis Inc.
- 12.2.24. Natera, Inc.
- 12.2.25. Others

13. 360 Degree AnalystView

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us